Apogee Therapeutics, Inc.

APGE - Company ID 0001974640

Market cap$9.99 B

Rank#958

Filings262

Apogee Therapeutics, Inc. has filed 262 public company documents between 2023 and 2026. The most frequent type is insider trade (88 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchAPGE overview$9.99 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #958See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut APGE beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow APGE via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
10-K	Annual report	4mo ago2026-03-02	2025-12-31	View filing
10-K	Annual report	1y ago2025-03-03	2024-12-31	View filing
10-K	Annual report	2y ago2024-03-05	2023-12-31	View filing

Apogee Therapeutics, Inc.

Similar companies to research next

Year